Fig. 2
From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
Overall survival (OS) estimated according to the expression level of galectin-1. The expression level of galectin-1 was a significant factor of OS (p = 0.009)